MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0028380
Dicore Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.34 Lakh
▼ 21% YoY
Net profit · FY 2024
₹1,184
Net margin 0.1%
EBITDA · FY 2024
₹5,059
EBITDA margin 0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Dicore Pharmaceuticals Private Limited
Data last updated:
Dicore Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC224334. Its GSTIN is 23AADCD9920A1Z5 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rupa Gupta and Sanjeev Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 201 Plot No. E 46 A Vishwas Park Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.34 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹1,184 (net margin 0.1%) and EBITDA of ₹5,059 (EBITDA margin 0.6%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 24% over five years.
The company is associated with 1 brand: Dicore Pharmaceuticals.
Dicore Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0028380). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dicorepharma.com.
Company details
CIN U24232DL2011PTC224334
Registration Number 224334
Incorporation Date 30 August 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0028380
Key People
Rupa Gupta Director Sanjeev Gupta Director Recognitions & Rankings of Dicore Pharmaceuticals
Contact details
Dicore Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is dicorepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit 201 Plot No. E 46 A Vishwas Park Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Dicore Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Dicore Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Dicore Pharmaceuticals operates one associated brand: Dicore Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and sales of pharmaceuticals, supplements, herbal medicines, and orthotic products in India. | dicorepharma.com |
Business activity
The main business activity of Dicore Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dicore Pharmaceuticals Private Limited, buy the company report.
Financials of Dicore Pharmaceuticals Private Limited
FY 2025 filings availableDicore Pharmaceuticals Private Limited reported revenue of ₹8.34 Lakh (down 21% YoY) for FY 2024.
Revenue · FY 2024
₹8.34 Lakh ▼ 21%
Net profit · FY 2024
₹1,184 margin 0.1%
EBITDA · FY 2024
₹5,059 margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 1%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▲ 156%
3 years · compounded
▲ 27%
5 years · compounded
▼ 23%
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 21% fall in the latest year. EBITDA rose 156% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,059 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,184 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dicore Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dicore Pharmaceuticals Private Limited
Dicore Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupa Gupta | Director | 30 Aug 2011 | 15 Years 1 Months | Current |
| Sanjeev Gupta | Director | 30 Aug 2011 | 15 Years 1 Months | Current |
Auditor
Dicore Pharmaceuticals Private Limited is audited by ROHIT RAJU & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROHIT RAJU & ASSOCIATES | FY 2017 | 078787 |
Shareholding
The shareholding of Dicore Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dicore Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dicore Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dicore Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dicore Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AADCD9920A1Z5 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dicore Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dicore Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Rupa Gupta was appointed as Director on 30 Aug 2011.
AGM
Dicore Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dicore Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Rupa Gupta was appointed as Director.
Appointed
Sanjeev Gupta was appointed as Director.
Incorporation
30 Aug 2011
Dicore Pharmaceuticals Private Limited was registered on 30 Aug 2011 with Roc Delhi & aged 15 years 1 month as per MCA records.
Frequently asked questions
Dicore Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 August 2011 (15+ years old) and is registered under CIN U24232DL2011PTC224334.
Dicore Pharmaceuticals has 2 current directors:
- Rupa Gupta - Director
- Sanjeev Gupta - Director
The latest financial statements of Dicore Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dicore Pharmaceuticals is 23AADCD9920A1Z5, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Dicore Pharmaceuticals is U24232DL2011PTC224334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dicore Pharmaceuticals was incorporated on 30 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Rupa Gupta was appointed as Director on 30 Aug 2011. Sanjeev Gupta was appointed as Director on 30 Aug 2011.
Yes, Dicore Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0028380).
Dicore Pharmaceuticals can be reached through the website dicorepharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Dicore Pharmaceuticals is at Unit 201 Plot No. E 46 A Vishwas Park Uttam Nagar, New Delhi, Delhi, India – 110059.